HomeCompareMTHRF vs NNN

MTHRF vs NNN: Dividend Comparison 2026

MTHRF yields 2.46% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTHRF wins by $161.05M in total portfolio value
10 years
MTHRF
MTHRF
● Live price
2.46%
Share price
$11.00
Annual div
$0.27
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$161.08M
Annual income
$149,403,565.09
Full MTHRF calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — MTHRF vs NNN

📍 MTHRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTHRFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTHRF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MTHRF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTHRF
Annual income on $10K today (after 15% tax)
$208.98/yr
After 10yr DRIP, annual income (after tax)
$126,993,030.33/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, MTHRF beats the other by $126,990,788.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTHRF + NNN for your $10,000?

MTHRF: 50%NNN: 50%
100% NNN50/50100% MTHRF
Portfolio after 10yr
$80.55M
Annual income
$74,703,101.25/yr
Blended yield
92.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

MTHRF
No analyst data
Altman Z
5.7
Piotroski
4/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTHRF buys
0
NNN buys
0
No recent congressional trades found for MTHRF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTHRFNNN
Forward yield2.46%5.68%
Annual dividend / share$0.27$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%8.6%
Portfolio after 10y$161.08M$25.6K
Annual income after 10y$149,403,565.09$2,637.42
Total dividends collected$160.18M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MTHRF vs NNN ($10,000, DRIP)

YearMTHRF PortfolioMTHRF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$11,192$491.71$10,737$617.02+$455.00MTHRF
2$13,004$1,028.61$11,577$710.93+$1.4KMTHRF
3$16,148$2,233.93$12,538$822.59+$3.6KMTHRF
4$22,463$5,185.18$13,645$956.06+$8.8KMTHRF
5$37,518$13,482.48$14,925$1,116.51+$22.6KMTHRF
6$82,235$42,090.44$16,415$1,310.57+$65.8KMTHRF
7$260,433$172,441.90$18,158$1,546.77+$242.3KMTHRF
8$1,299,435$1,020,771.54$20,213$1,836.20+$1.28MMTHRF
9$10,910,302$9,519,905.91$22,649$2,193.37+$10.89MMTHRF
10$161,077,588$149,403,565.09$25,558$2,637.42+$161.05MMTHRF

MTHRF vs NNN: Complete Analysis 2026

MTHRFStock

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Full MTHRF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this MTHRF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTHRF vs SCHDMTHRF vs JEPIMTHRF vs OMTHRF vs KOMTHRF vs MAINMTHRF vs ADCMTHRF vs EPRTMTHRF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.